Technology Wire Cambodia
SEE OTHER BRANDS

Hottest science and technology news from Cambodia

Technology Wire Cambodia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.

Press releases published on June 9, 2025

Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum

Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum

HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTC:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity …

NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial

NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial

-- Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both the full ITT population (p<0.002) and in ApoE4 …

Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025

Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025

SAN MATEO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced it will host a …

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced that Patient 009 in the Phase 1 trial of …

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

Preclinical data highlighted JADE101’s femtomolar APRIL binding affinity, extended non-human primate half-life of approximately 27 days, and sustained IgA suppression In non-human primates, JADE101 showed a differentiated pharmacokinetic and …

TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial

TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial

- For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity (AGV) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over 26 weeks - For the TransCon CNP-treated cohort, combination …

Keros Announces Return of $375 Million in Excess Capital to Stockholders

Keros Announces Return of $375 Million in Excess Capital to Stockholders

LEXINGTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of …

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for May 2025 of its Virtune Crypto Altcoin Index ETP

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for May 2025 of its Virtune Crypto Altcoin Index ETP

Stockholm, 9th of June 2025 – Virtune AB (Publ) ("Virtune") today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm and Nasdaq Helsinki (ISIN code SE0023260716). In addition to the …

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för maj 2025 av Virtune Crypto Altcoin Index ETP

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för maj 2025 av Virtune Crypto Altcoin Index ETP

Stockholm, 9 juni 2025 – Virtune meddelar idag att man har slutfört den månatliga rebalanseringen av Virtune Crypto Altcoin Index ETP, noterad på Nasdaq Stockholm och Nasdaq Helsinki (ISIN-kod SE0023260716). Utöver Virtune Crypto Altcoin Index ETP omfattar …

Quid Miner's new application dominated the hot search list as soon as it was launched

Quid Miner's new application dominated the hot search list as soon as it was launched

Houston, TX, June 09, 2025 (GLOBE NEWSWIRE) -- Quid Miner recently launched a new mobile app: allowing users to mine easily anytime and anywhere. As a green cloud mining platform established legally and compliantly in the UK. It provides mining services …

$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed

$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed

Panama City, Panama, June 09, 2025 (GLOBE NEWSWIRE) -- In a sea of derivatives and half-baked memes, $ZEUS is setting a new standard, not just for meme coins, but for storytelling, ownership, and community-driven culture on-chain. Over the past 48 hours, $ …

Red Cat Supports Executive Orders to Strengthen U.S. Drone Manufacturing and National Security

Red Cat Supports Executive Orders to Strengthen U.S. Drone Manufacturing and National Security

SAN JUAN, Puerto Rico, June 09, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today issued a statement of support …

Portage Biotech and Compedica Stock-for-Stock Exchange

Portage Biotech and Compedica Stock-for-Stock Exchange

DOVER, Del., June 09, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”) announce that on June 5, 2025 Portage and Compedica Holdings …

YXT.com's AI Learning Platform Deployed by Siemens for Digital Workforce Transformation

YXT.com's AI Learning Platform Deployed by Siemens for Digital Workforce Transformation

SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that the global industrial technology leader Siemens has …

WAYS.cash Wins Grand Champion Title at Solrift Hackathon for Privacy-Focused Payment Toolkit

WAYS.cash Wins Grand Champion Title at Solrift Hackathon for Privacy-Focused Payment Toolkit

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- WAYS.cash, the first self-custodial stealth-address payment toolkit on Solana, has been named Grand Champion of the “A Breach in the Norm” hackathon hosted by Solrift. The win earned the New York–based project a …

CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform

CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform

Lehi, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that it will expand its preclinical program to …

AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans

AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans

COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE L'APPROBATION PAR L'EMA DE LA PROLONGATION DE LA DURÉE DE CONSERVATION DE MASIVET® À 4 ANS Paris, 9 juin 2025, 8h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que l'Agence européenne des …

AB Science announces EMA approval of Masivet shelf-life extension to 4 years

AB Science announces EMA approval of Masivet shelf-life extension to 4 years

PRESS RELEASE AB SCIENCE ANNOUNCES EMA APPROVAL OF MASIVET® SHELF-LIFE EXTENSION TO 4 YEARS Paris, June 9, 2025, 8am CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Medicine Agency (EMA) has approved the extension of the …

UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING

UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING

UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING Nantes, June 9th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) informs its shareholders and the market of the update on the terms of the Combined General Meeting scheduled …

MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE

MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE

MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE Nantes, France, 9 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), informe ses actionnaires et le marché de la mise à jour des modalités de l’Assemblée Générale Mixte …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service